Edition:
United States

Alnylam Pharmaceuticals Inc (ALNY.O)

ALNY.O on Nasdaq

67.04USD
29 Apr 2016
Change (% chg)

$-0.84 (-1.24%)
Prev Close
$67.88
Open
$67.68
Day's High
$68.23
Day's Low
$66.40
Volume
426,201
Avg. Vol
992,539
52-wk High
$140.00
52-wk Low
$51.51

ALNY.O

Chart for ALNY.O

About

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the research and development of therapeutics based on its ribonucleic acid interference (RNAi). The Company’s pipeline focuses in three strategic therapeutic areas (STArs): Genetic Medicines, with a pipeline of RNAi therapeutics for the... (more)

Overall

Beta: 2.47
Market Cap(Mil.): $5,722.22
Shares Outstanding(Mil.): 85.36
Dividend: --
Yield (%): --

Financials

  ALNY.O Industry Sector
P/E (TTM): -- 62.99 45.44
EPS (TTM): -3.45 -- --
ROI: -25.13 3.21 12.52
ROE: -26.36 4.47 13.40
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks